View drug registration information details.


ItemsRegistration information
ID1257
No1257
Brand NameLAKAS TABLET 5 MG
IngredientsMONTELUKAST SODIUM EQ. TO MONTELUKAST 5 MG
Dosage FormTABLET
Primary PackagingALU-ALU
StorageSTORE BELOW 30 C
Shelf Life2 YEARS
Pack Size1 X 10'S/BOX
Dispensing CategoryPrescription only
ATC ClassificationXX
Pharmaceutical ClassANTIASTHMA
IndicationsTREATMENT OF ASTHMA AS ADD-ON THERAPY IN ADULTS AND CHILDREN WITH MILD TO MODERATE PERSISTENT ASTHMA WHO ARE INADEQUATELY CONTROLLED ON INHALED CORTICOSTEROID AND IN WHOM AS NEEDED SHORT ACTING BETA-AGONISTS PROVIDE INADEQUATE CLINICAL CONTROL OF ASTHMA.
ContraindicationsHYPERSENSITIVITY
Side EffectsUPPER RESPIRATORY INFECTION, FEVER, HEADACHE, PHARYNGITIS, COUGH, ABDOMINAL PAIN, DIARRHEA, OTITIS MEDIA, INFLUENZA, SINUSITIS
Unit Price0.41
EDL Yes
DescriptionLIGHT PEACH COLORED ROUND SHAPED BICONVEXED TABLETS PLAIN ON BOTH SIDES
Note
License OwnerKONGCHAI-LAO PHARMA SOLE CO.,LTD
ManufacturerFOCUS & RULZ PHARMACEUTICALS (PVT) LTD
CountryPAKISTAN
Import Registration No49293
Import Registration Date2008-07-10
ActivityCERTIFICATE RELEASED
Applied Date2024-03-22
FDD Registration No04 I 4666/19
FDD Registration Date2024-06-22
Expiry Date2027-06-21

Back to drug list